Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity

Conventional serum antibody titer, which expresses antibody level, does not provide antigen binding avidity of the variable region of the antibody, which is essential for the defense response to infection. Here, we quantified anti-SARS-CoV-2 antibody binding avidity to the receptor-binding domain (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Etsuhisa, Sawabuchi, Takako, Homma, Tetsuya, Fukuda, Yosuke, Sagara, Hironori, Kinjo, Takeshi, Fujita, Kaori, Suga, Shigeru, Kimoto, Takashi, Sakai, Satoko, Kameda, Keiko, Kido, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459795/
https://www.ncbi.nlm.nih.gov/pubmed/37632005
http://dx.doi.org/10.3390/v15081662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459795/
https://www.ncbi.nlm.nih.gov/pubmed/37632005
http://dx.doi.org/10.3390/v15081662

Ejemplares similares